Skip to main content
Equibles

Rathbones Group PLC

Position in IBRX — ImmunityBio, Inc.

CIK 1351991 Liverpool, X0
Back to IBRX Full portfolio

Position in IBRX

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$1,428,991
+$252,260 QoQ
Shares Held
163,220
+6.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 404 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rathbones Group PLC holds $10,663,603 across 18 Biotechnology names. IBRX ranks #2 (13.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 23,500 $1,916,895
2 IBRX
ImmunityBio, Inc.
This page 		163,220 $1,428,991
3 XENE
Xenon Pharmaceuticals Inc.
 23,166 $1,398,299
4 ORMP
Oramed Pharmaceuticals Inc.
 233,018 $1,120,816
5 DFTX
Definium Therapeutics, Inc.
 22,800 $1,072,512
6 CORT
Corcept Therapeutics Inc
 11,790 $1,025,140
7 MRNA
Moderna, Inc.
 9,474 $663,464
8 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,044 $518,586

All Filings in IBRX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,428,991 163,220
2026-03-31 $1,176,731 153,420
2025-12-31 $319,611 161,420
2025-09-30 $397,093 161,420
2025-06-30 $309,988 117,420
2025-03-31 $290,826 96,620
2024-12-31 $228,915 89,420
2024-09-30 $273,122 73,420
2024-06-30 $464,014 73,420
2024-03-31 $394,265 73,420
2023-12-31 $368,568 73,420
2023-09-30 $124,079 73,420